INMUNE BIO INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
INMUNE BIO INC. (INMB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 16.13 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-03
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 17.86M shares, a 32.67% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 17.33M shares, a 34.06% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 14.97M shares, a 38.65% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 14.32M shares, a 33.27% increase year-over-year.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 16.13M shares, a 34.55% increase from fiscal 2020.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 11.99M shares, a 16.70% increase from fiscal 2019.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 10.27M shares, a 18.39% increase from fiscal 2018.
- INMUNE BIO INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 8.68M shares, a 32.18% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 17.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 17.60M shares derived: average of 2 quarters · filed 2022-03-03 | 16.72M shares derived: average of 3 quarters · filed 2022-03-03 | 16.13M shares 10-K · filed 2022-03-03 |
| 2021-09-30 | 17.33M shares 10-Q · filed 2021-11-03 | 16.15M shares derived: average of 2 quarters · filed 2021-11-03 | 15.55M shares 10-Q · filed 2021-11-03 | 15.02M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2021-06-30 | 14.97M shares 10-Q · filed 2021-08-04 | 14.65M shares 10-Q · filed 2021-08-04 | 14.25M shares derived: average of 3 quarters · filed 2022-03-03 | 13.92M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2021-03-31 | 14.32M shares 10-Q · filed 2021-05-05 | 13.89M shares derived: average of 2 quarters · filed 2022-03-03 | 13.57M shares derived: average of 3 quarters · filed 2022-03-03 | 12.88M shares derived: average of 4 quarters · filed 2022-03-03 |
| 2020-12-31 | 13.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 13.20M shares derived: average of 2 quarters · filed 2022-03-03 | 12.40M shares derived: average of 3 quarters · filed 2022-03-03 | 11.99M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 12.93M shares 10-Q · filed 2021-11-03 | 11.86M shares derived: average of 2 quarters · filed 2021-11-03 | 11.50M shares 10-Q · filed 2021-11-03 | 11.31M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | 10.80M shares 10-Q · filed 2021-08-04 | 10.77M shares 10-Q · filed 2021-08-04 | 10.77M shares derived: average of 3 quarters · filed 2021-08-04 | 10.77M shares derived: average of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | 10.75M shares 10-Q · filed 2021-05-05 | 10.76M shares derived: average of 2 quarters · filed 2021-05-05 | 10.76M shares derived: average of 3 quarters · filed 2021-05-05 | 10.61M shares derived: average of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | 10.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 10.77M shares derived: average of 2 quarters · filed 2021-03-04 | 10.56M shares derived: average of 3 quarters · filed 2021-03-04 | 10.27M shares 10-K · filed 2021-03-04 |
| 2019-09-30 | 10.76M shares 10-Q · filed 2020-11-05 | 10.46M shares derived: average of 2 quarters · filed 2020-11-05 | 10.11M shares 10-Q · filed 2020-11-05 | 9.76M shares derived: average of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 10.15M shares 10-Q · filed 2020-08-05 | 9.77M shares 10-Q · filed 2020-08-05 | 9.42M shares derived: average of 3 quarters · filed 2020-08-05 | 9.24M shares derived: average of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | 9.39M shares 10-Q · filed 2020-05-14 | 9.05M shares derived: average of 2 quarters · filed 2020-05-14 | 8.94M shares derived: average of 3 quarters · filed 2020-05-14 | 8.89M shares derived: average of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | 8.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 8.72M shares derived: average of 2 quarters · filed 2020-03-11 | 8.72M shares derived: average of 3 quarters · filed 2020-03-11 | 8.68M shares 10-K · filed 2020-03-11 |
| 2018-09-30 | 8.72M shares 10-Q · filed 2019-11-08 | 8.72M shares derived: average of 2 quarters · filed 2019-11-08 | 8.66M shares 10-Q · filed 2019-11-08 | |
| 2018-06-30 | 8.72M shares 10-Q · filed 2019-08-09 | 8.63M shares 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | 8.55M shares 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | 6.56M shares 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |